Autism spectrum disorders (ASD) are a complex group of neurodevelopmental disorders encompassing impairments in communication, social interactions and restricted stereotypical behaviors. Although a link between altered immune responses and ASD was first recognized nearly 40 years ago, only recently has new evidence started to shed light on the complex multifaceted relationship between immune dysfunction and behavior in ASD. Neurobiological research in ASD has highlighted pathways involved in neural development, synapse plasticity, structural brain abnormalities, cognition and behavior. At the same time, several lines of evidence point to altered immune dysfunction in ASD that directly impacts some or all these neurological processes. Extensive alterations in immune function have now been described in both children and adults with ASD, including ongoing inflammation in brain specimens, elevated pro-inflammatory cytokine profiles in the CSF and blood, increased presence of brain-specific auto-antibodies and altered immune cell function. Furthermore, these dysfunctional immune responses are associated with increased impairments in behaviors characteristic of core features of ASD, in particular, deficits in social interactions and communication. This accumulating evidence suggests that immune processes play a key role in the pathophysiology of ASD. This review will discuss the current state of our knowledge of immune dysfunction in ASD, how these findings may impact on underlying neuro-immune mechanisms and implicate potential areas where the manipulation of the immune response could have an impact on behavior and immunity in ASD.
Introduction
Autism spectrum disorders (ASD) are a series of pervasive development disorders which include autistic disorder, Rett's disorder, childhood disintegrative disorder, Asperger's syndrome or pervasive developmental disorder not otherwise specified (PDD-NOS). Autism spectrum disorders are characterized by severe and pervasive impairment in several areas of development: reciprocal social interaction skills, communication skills, or the presence of stereotyped behavior, interests and activities (APA, 2000) . According to the most recent estimates calculated by the US Center of Disease Control, ASD affects 1 in 110 children under the age of eight (MMWR, 2009) . Although current research suggests there may be no single genetic cause for ASD, there are several lines of evidence to suggest that the disorder is highly heritable. There is a concordance rate for ASD of 0-37% reported for dizygotic twins, while concordance rates of 44-91% are reported for monozygotic twins (Bailey et al., 1995; Constantino and Todd, 2000; Kates et al., 2004; Steffenburg et al., 1989) , suggesting that genetic composition may contribute to increased risk of developing ASD. In addition to the heritability observed in twin-pairs, the risk of developing ASD in non-twin siblings is increased 25-fold in comparison to the general population (Jorde et al., 1991) . While the heritability of ASD suggests a genetic component in the disorders etiology, the genes involved vary greatly among individuals and family clusters.
Whole-genome linkage studies, gene association studies, copy number variation screening and SNP analyses have uncovered a large number of ASD candidate genes (Abrahams and Geschwind, 2008) et al., 2005) . Furthermore, in several syndromic disorders with single gene mutations, including Rett's syndrome (MeCP2) (Nagarajan et al., 2008) , Fragile X (FMR1) (Belmonte and Bourgeron, 2006) , tuberous sclerosis (either TSC1 or TSC2) (Wiznitzer, 2004) , Timothy syndrome (CACNA1C), Cowden's syndrome (PTEN), and Angelman's syndrome (UBE3A) the occurrence of ASD is higher than the general population. Among these potential candidate genes several play important roles in immune function. Proteins within the phosphoinositide-3-kinase (PI3K) pathway, including those coded by MET, PTEN, TSC1 and TSC2, have a major role in regulating
